Tell us what you think about Healio
Sign in for a personal experience.
Customized content served to meet your interests.
The FDA has announced they will allow the marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay for the diagnosis of diabetes by health care professionals, according to a press release.
Investigators analyzed 141 blood samples and found a difference of <6% in accuracy between the Tina-quant HbA1cDx assay (Roche) and results from standard reference for HbA1c analysis, according to the release.
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.
View past polls »
©2013 All Rights Reserved.